Reunert Ltd buy krebskrebs
Start price
30.11.20
/
50%
€2.14
Target price
30.11.21
€3.00
Performance (%)
22.43%
End price
01.12.21
€2.62
Summary
This prediction ended on 01.12.21 with a price of €2.62. The prediction had a final performance of 22.43%. A total of €0.11 was paid as dividends for this prediction. krebskrebs has 50% into this predictionPerformance without dividends (%)
Name | 1w | 1m | 1y | 3y |
---|---|---|---|---|
Reunert Ltd | -2.073% | -2.073% | 32.168% | 21.154% |
iShares Core DAX® | -3.429% | 5.085% | 15.455% | 12.600% |
iShares Nasdaq 100 | -6.121% | 0.593% | 16.379% | 27.048% |
iShares Nikkei 225® | -7.364% | 5.479% | 6.970% | -3.061% |
iShares S&P 500 | -4.366% | 2.019% | 18.650% | 32.317% |
Comments by krebskrebs for this prediction
In the thread Reunert Ltd diskutieren
Buy mit Kursziel 3,0
In the thread Trading Reunert Ltd
Die von krebskrebs gewählte maximale Laufzeit wurde überschritten